A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release.
Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.
Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.
A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.
A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent (NEUROMUSCULAR NONDEPOLARIZING AGENTS). It is used as a muscle relaxant during ANESTHESIA and surgical procedures.
A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of TUBOCURARINE, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
The synapse between a neuron and a muscle.
A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.
Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups.
Anesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.
The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.
A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.
A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
The branch of surgery concerned with restoration, reconstruction, or improvement of defective, damaged, or missing structures.
A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)
The first digit on the radial side of the hand which in humans lies opposite the other four.
A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Procedure in which patients are induced into an unconscious state through use of various medications so that they do not feel pain during surgery.
A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Effects of priming with pancuronium or rocuronium on intubation with rocuronium in children. (1/175)

Rocuronium is a non-depolarizing neuromuscular blocking agent which has a rapid onset and intermediate duration of action. The goal of this study was to compare the neuromuscular blocking actions of rocuronium with and without a priming dose of pancuronium or rocuronium in children. Thirty patients were randomly allocated into 3 groups. Ten patients received a single dose of 0.6 mg/kg rocuronium (Group I). The others received either 0.015 mg/kg pancuronium (Group II) or 0.06 mg/kg rocuronium (Group III) 3 minutes before an intubating dose of 0.54 mg/kg rocuronium was given. Neuromuscular blockade was measured via accelerographic response to single stimulations (1 Hz) of the ulnar nerve until maximal twitch depression was reached followed by train-of-four (TOF) stimuli (2 Hz) at 15 second intervals for the remainder of recovery. Groups were compared with regard to onset time, duration and recovery indices. The onset time and duration of block did not differ significantly between groups. However, the time to recovery in group II (24.5 +/- 9.9 min) was significantly prolonged compared to that in group I (12.7 +/- 3.1 min) or group III (12.7 +/- 3.9 min). We concluded that the use of rocuronium with a preceding dose of either pancuronium or rocuronium provided no advantage for intubation in children.  (+info)

Paralysis of ventilated newborn babies does not influence resistance of the total respiratory system. (2/175)

Paralysis with pancuronium bromide is used in newborn infants to facilitate ventilatory support during respiratory failure. Changes in lung mechanics have been attributed to paralysis. The aim of this study was to examine whether or not paralysis per se has an influence on the passive respiratory mechanics, resistance (Rrs) and compliance (Crs) of the respiratory system in newborn infants. In 30 infants with acute respiratory failure, Rrs was measured during paralysis with pancuronium bromide and after stopping pancuronium bromide (group A). Rrs was also measured in an additional 10 ventilated infants in a reversed fashion (group B): Rrs was measured first in nonparalysed infants and then they were paralysed, mainly for diagnostic procedures, and the Rrs measurement repeated. As Rrs is highly dependent on lung volume, several parameters, that depend directly on lung volume were recorded: inspiratory oxygen fraction (FI,O2), arterial oxygen tension/alveolar oxygen tension (a/A) ratio and volume above functional residual capacity (FRC). In group A, the Rrs was not different during (0.236+/-0.09 cmH2O x s x mL(-1)) and after (0.237+/-0.07 cmH2O x s x mL(-1)) paralysis. Also, in group B, Rrs did not change (0.207+/-0.046 versus 0.221+/-0.046 cm x s x mL(-1) without versus with pancuronium bromide). FI,O2, a/A ratio and volume above FRC remained constant during paralysis. These data demonstrate that paralysis does not influence the resistance of the total respiratory system in ventilated term and preterm infants when measured at comparable lung volumes.  (+info)

Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue obtained during cardiac surgery. (3/175)

We have studied the effect of non-depolarizing neuromuscular blocking agents, at concentrations present in serum during anaesthesia, on release of [3H]-norepinephrine ([3H]NE) from superfused atrial appendage obtained during cardiac surgery from 48 patients. Three of the neuromuscular blocking agents (pancuronium, gallamine and rocuronium), which are known to cause an increase in heart rate during anaesthesia, increased stimulation-evoked release of [3H]NE. In contrast, (+)tubocurarine and pipecuronium, neuromuscular blocking agents that do not cause tachycardia, did not affect release of NE. Org 9487 significantly enhanced release while SZ1677 was ineffective, even at concentrations higher than those expected after administration of a 2 x ED95 dose. Atropine enhanced release. These data suggest that the axon terminals of sympathetic nerves in human heart have muscarinic heteroreceptors whose activation by acetylcholine (ACh) released from the vagal nerve reduces release of NE. This action contributes to lowering of heart rate. Therefore, any neuromuscular blocking agent with antimuscarinic actions and capable of increasing the release of NE may produce tachycardia.  (+info)

Residual neuromuscular block caused by pancuronium after cardiac surgery. (4/175)

We studied 20 adult patients undergoing cardiac surgery. All received pancuronium as the sole neuromuscular blocking drug and no reversal agent was used. In the postoperative intensive care unit, mechanical ventilation was continued and patients were sedated with an infusion of propofol. Neuromuscular block was measured electromyographically at appropriate intervals until the train-of-four ratio (TOF) reached 0.8. At the time when the propofol infusion would normally be discontinued, 13 patients (65%) demonstrated a TOF of less than 0.8 (group median 0.23, interquartile range 0.11-0.6). Subsequently, the median time to achieve a TOF of 0.8 was 2 h 10 min (interquartile range 1 h-2 h 25 min). We found that if pancuronium was used during cardiac surgery, a significant proportion of patients remained partially paralysed when they would normally be allowed to emerge from anaesthesia in the ICU.  (+info)

Evidence for a peripheral mechanism of esophagocrural diaphragm inhibitory reflex in cats. (5/175)

The esophagogastric junction (EGJ) is guarded by two sphincters, a smooth muscle lower esophageal sphincter (LES) and a skeletal muscle crural diaphragm. These two sphincters relax simultaneously under certain physiological conditions, i.e., swallowing, belching, vomiting, transient LES relaxation, and esophageal distension. Esophageal distension-induced crural diaphragm relaxation is mediated through vagal afferents that are thought to exert inhibitory influence on the central mechanism (brain stem) of crural diaphragm contraction. We conducted studies in 10 cats to determine whether a mechanism of crural diaphragm relaxation was located at the level of the neuromuscular junction and/or muscle. Stimulation of the crural diaphragm neuromuscular junction through 1) the electrodes implanted in the muscle and 2) the bilateral phrenic nerve resulted in an increase in EGJ pressure. Nicotinic receptor blockade (pancuronium, 0.2 mg/kg) abolished the EGJ pressure increase caused by electrical stimulation of the neuromuscular junction. Esophageal distension and bolus-induced secondary esophageal peristalsis caused relaxation of the EGJ during the stimulation of the neuromuscular junction. Bilateral phrenicotomy and vagotomy had no influence on this relaxation. These data suggest the existence of a peripheral mechanism of crural diaphragm inhibition. This peripheral inhibitory mechanism may reside at the level of either the neuromuscular junction or the skeletal muscle.  (+info)

Effect of pipecuronium and pancuronium on intracranial pressure and cardiovascular parameters in patients with supratentorial tumours. (6/175)

A prospective, randomised, single blind study was conducted to evaluate and compare the intracranial pressure (ICP) and cardiovascular effects of pipecuronium (PPC) and pancuronium (PNC) in 20 patients undergoing supratentorial surgery. Patients were randomly divided into two groups. Patients in Group I (n = 10) received pancuronium (0.1 mg kg(-1)) and in Group II (n = 10) pipecuronium (0.07 mg kg(-1)) for intubation. Intracranial pressure (ICP), heart rate (HR), systolic, diastolic and mean arterial pressures (SAP, DAP, MAP), central venous pressure (CVP), nasopharyngeal temperature and arterial blood gases (ABG) were monitored at the following time periods: before induction (0 minutes); 3 minutes after thiopentone and muscle relaxant; immediately after intubation; and 4, 6, 8, 10, 20 and 30 minutes following intubation. The rise in intracranial pressure at intubation was significantly greater in group I (21.10+/-3.97 torr, 122.59%) when compared to group II patients (1.80+/-0.70 torr, 10.04%) (p<0.0 1). Cardiovascular parameters also showed a significantly greater degree of rise in group I when compared to group II patients. Heart rate increased by 29+/-6.32 beats min(-1) (33.52%) and systolic arterial pressure by 11.60+/-7.37 torr (9.47%) in group I. These parameters did not change significantly in group II. No significant alterations were observed in the other measured parameters in either of the two groups.  (+info)

Prolongation of pancuronium-induced neuromuscular blockade by intravenous infusion of nitroglycerin. (7/175)

Based upon clinical observation of undue prolongation of pancuronium-induced blockade in the presence of intravenous infusion of nitroglycerin, neuromuscular blockades produced by pancuronium, succinylcholine and d-tubocurarine were studied in 51 cats using the sciatic-gastrocnemius nerve-muscle preparation. Pancuronium-induced blockade was found to be significantly prolonged (P less than 0.1) in the presence of a nitroglycerin infusion of 1 microgram/kg/min (65 vs. 127 min). Less, but still significant, prolongation occurred when nitroglycerin, 0.5 microgram/kg/min, was infused. The intravenous infusion of nitroglycerin must be started prior to the pancuronium injection for the block to be prolonged. Neuromuscular blocks produced by succinylcholine and d-tubocurarine were not altered by nitroglycerin. In experiments using the isolated rat diaphragm preparation, the depth of pancuronium-induced block was found not to be changed by nitroglycerin, suggesting an effect of nitroglycerin on the process of recovery from blockade. These findings indicate a selective pancuronium-nitroglycerin interaction.  (+info)

Postoperative residual paralysis and respiratory status: a comparative study of pancuronium and vecuronium. (8/175)

The objective of this prospective double-blind study was to determine whether postoperative residual paralysis (PORP) after pancuronium or vecuronium results in hypoxemia and hypercapnia in the immediate admission period to the recovery ward. Eighty-three consecutive surgical patients received balanced or intravenous anesthesia with pancuronium for operations lasting longer than one hour or vecuronium for those lasting less than 60 min, both combined with neostigmine at the end of anesthesia. Standard clinical criteria assessed neuromuscular function intraoperatively. Postoperatively, we determined neuromuscular function (acceleromyography with supramaximal train-of-four (TOF) stimulation of the ulnar nerve, and a 5-s head lift) and pulmonary function (pulse oximetry: SpO2, and blood gas analysis: SaO2, PaCO2). We defined PORP as a TOF-ratio <70%, hypoxemia as a postoperative SpO2 > or =5% below the pre-anesthestic level together with a postoperative SaO2 <93%, and hypercapnia as a PaCO2 > or =46 mm Hg. Among the 49 pancuronium and 27 vecuronium patients studied, the PORP rates were 20% in the pancuronium group and 7% in the vecuronium group (p>0.05). Hypoxemia and hypercapnia occurred more often in pancuronium patients with PORP than in those without PORP namely 60% vs. 10% (p<0.05) and 30% vs. 8% (p>0.05), respectively. We conclude that PORP after pancuronium is a significant risk factor for hypoxemia.  (+info)

Pancuronium is defined as a non-depolarizing neuromuscular blocking agent, which is used in anesthesia practice to provide skeletal muscle relaxation during surgery. It works by competitively inhibiting the binding of acetylcholine to nicotinic receptors at the motor endplate, thereby preventing muscle contraction. Pancuronium has a intermediate duration of action and is often used for routine surgical procedures requiring muscle relaxation. It is administered intravenously and is typically reversed with an anticholinesterase agent such as neostigmine at the conclusion of surgery.

Neuromuscular blocking agents (NMBAs) are a class of drugs that act on the neuromuscular junction, the site where nerve impulses transmit signals to muscles to cause contraction. NMBAs prevent the transmission of these signals, leading to muscle paralysis. They are used in medical settings during surgical procedures and mechanical ventilation to facilitate intubation, control ventilation, and prevent patient movement. It is important to note that NMBAs do not have any effect on consciousness or pain perception; therefore, they are always used in conjunction with anesthetics and analgesics.

NMBAs can be classified into two main categories based on their mechanism of action:

1. Depolarizing Neuromuscular Blocking Agents: These drugs, such as succinylcholine, cause muscle fasciculations (brief, involuntary contractions) before inducing paralysis. They work by binding to the acetylcholine receptors at the neuromuscular junction and depolarizing the membrane, which results in muscle paralysis. However, the continuous depolarization also causes desensitization of the receptors, leading to a loss of effectiveness over time. Depolarizing NMBAs have a relatively short duration of action.
2. Non-depolarizing Neuromuscular Blocking Agents: These drugs, such as rocuronium, vecuronium, and pancuronium, do not cause muscle fasciculations. They work by binding to the acetylcholine receptors at the neuromuscular junction without depolarizing the membrane, which prevents the transmission of nerve impulses to muscles and leads to paralysis. Non-depolarizing NMBAs have a longer duration of action compared to depolarizing NMBAs.

Close monitoring of neuromuscular function is essential when using NMBAs to ensure adequate reversal of their effects before the patient regains consciousness. This can be achieved through the use of nerve stimulators, which assess the degree of blockade and help guide the administration of reversal agents when necessary.

Vecuronium Bromide is a neuromuscular blocking agent, which is a type of medication that acts on the muscles to cause paralysis. It is used in anesthesia during surgery to provide skeletal muscle relaxation and to facilitate endotracheal intubation and mechanical ventilation. Vecuronium Bromide works by blocking the transmission of nerve impulses at the neuromuscular junction, the site where nerves meet muscles. This results in temporary paralysis of the muscles, allowing for controlled muscle relaxation during surgical procedures. It is a non-depolarizing muscle relaxant and is considered to have a intermediate duration of action.

Neuromuscular non-depolarizing agents are a type of muscle relaxant medication used in anesthesia and critical care settings to facilitate endotracheal intubation, mechanical ventilation, and to prevent muscle contractions during surgery. These agents work by competitively binding to the acetylcholine receptors at the neuromuscular junction, without activating them, thereby preventing the initiation of muscle contraction.

Examples of non-depolarizing neuromuscular blocking agents include:

* Vecuronium
* Rocuronium
* Pancuronium
* Atracurium
* Cisatracurium
* Mivacurium

These medications have a reversible effect and their duration of action can be prolonged in patients with impaired renal or hepatic function, acid-base imbalances, electrolyte abnormalities, or in those who are taking other medications that interact with these agents. Therefore, it is important to monitor the patient's neuromuscular function during and after the administration of non-depolarizing neuromuscular blocking agents.

Tubocurarine is a type of neuromuscular blocking agent, specifically a non-depolarizing skeletal muscle relaxant. It works by competitively binding to the nicotinic acetylcholine receptors at the motor endplate, thereby preventing the binding of acetylcholine and inhibiting muscle contraction. Tubocurarine is derived from the South American curare plant and has been used in anesthesia to facilitate intubation and mechanical ventilation during surgery. However, its use has largely been replaced by newer, more selective agents due to its potential for histamine release and cardiovascular effects.

Atracurium is a non-depolarizing neuromuscular blocking agent (NMBDA) that is used in anesthesia practice to provide skeletal muscle relaxation during surgery. It works by competitively inhibiting the binding of acetylcholine to nicotinic receptors at the motor endplate, thereby preventing muscle contraction.

Atracurium has a rapid onset and intermediate duration of action, making it useful for a variety of surgical procedures. It is also known for its unique property of being broken down by Hofmann elimination, a non-enzymatic degradation process that occurs at physiological pH and temperature, which makes it independent of hepatic or renal function. This makes atracurium a useful option in patients with compromised liver or kidney function.

However, atracurium can cause histamine release, which may lead to hypotension, tachycardia, and bronchospasm, especially with rapid bolus administration. Therefore, it is usually administered by continuous infusion or intermittent boluses, titrated to the desired level of muscle relaxation.

It's important to note that atracurium should only be administered under the supervision of anesthesia professionals and used in accordance with the recommended dosages and monitoring guidelines to ensure patient safety.

Pipecuronium is a non-depolarizing neuromuscular blocking agent, which is a type of muscle relaxant used during surgical procedures. It works by binding to the receptors on the motor endplate at the neuromuscular junction and preventing the transmission of nerve impulses to the muscles, thereby causing paralysis. This allows for controlled muscle relaxation during surgery and intubation.

Pipecuronium has a long duration of action and is often used for procedures that require prolonged muscle relaxation. It is administered intravenously and is typically given in combination with general anesthesia. The dose of pipecuronium is adjusted based on the patient's weight, age, and other factors that may affect its pharmacokinetics and pharmacodynamics.

Like all medications, pipecuronium can have side effects, including decreased blood pressure, slow heart rate, and respiratory depression. It should be used with caution in patients with a history of allergies to muscle relaxants, neuromuscular disorders, or impaired kidney or liver function. Proper monitoring and management of the patient's airway, breathing, and circulation are essential during its use.

Succinylcholine is a neuromuscular blocking agent, a type of muscle relaxant used in anesthesia during surgical procedures. It works by inhibiting the transmission of nerve impulses at the neuromuscular junction, leading to temporary paralysis of skeletal muscles. This facilitates endotracheal intubation and mechanical ventilation during surgery. Succinylcholine has a rapid onset of action and is metabolized quickly, making it useful for short surgical procedures. However, its use may be associated with certain adverse effects, such as increased heart rate, muscle fasciculations, and potentially life-threatening hyperkalemia in susceptible individuals.

Edrophonium is a type of medication called an anticholinesterase agent. It works by blocking the breakdown of acetylcholine, a neurotransmitter in the body that is important for muscle contraction. This results in an increase in the amount of acetylcholine available to stimulate muscle contraction.

Edrophonium is used as a diagnostic aid in the diagnosis of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue. It is also used to reverse the effects of non-depolarizing muscle relaxants, which are medications that are sometimes given during surgery to temporarily paralyze muscles.

Edrophonium is administered intravenously (through a vein) and its effects usually begin within 30 seconds to 1 minute after injection and last for about 5 to 10 minutes. Common side effects of edrophonium include sweating, increased salivation, and muscle twitching. More serious side effects, such as seizures or cardiac arrest, can occur but are rare.

It is important to note that edrophonium should only be used under the supervision of a healthcare professional, as it can cause serious side effects if not used properly.

Gallamine triethiodide is not typically considered a medical term, but it is a pharmacological substance with historical use in anesthesia. It is a quaternary ammonium compound with muscarinic anticholinergic and skeletal muscle relaxant properties. The chemical formula for gallamine triethiodide is C17H24I3N2O2.

In a medical or clinical context, gallamine triethiodide has been used as an adjunct to general anesthesia to provide muscle relaxation during surgical procedures. However, due to its significant side effects and the availability of safer alternatives, it is no longer commonly used in modern anesthetic practice.

Neostigmine is a medication that belongs to a class of drugs called cholinesterase inhibitors. It works by blocking the breakdown of acetylcholine, a neurotransmitter in the body, leading to an increase in its levels at the neuromuscular junction. This helps to improve muscle strength and tone by enhancing the transmission of nerve impulses to muscles.

Neostigmine is primarily used in the treatment of myasthenia gravis, a neurological disorder characterized by muscle weakness and fatigue. It can also be used to reverse the effects of non-depolarizing muscle relaxants administered during surgery. Additionally, neostigmine may be used to diagnose and manage certain conditions that cause decreased gut motility or urinary retention.

It is important to note that neostigmine should be used under the close supervision of a healthcare professional due to its potential side effects, which can include nausea, vomiting, diarrhea, increased salivation, sweating, and muscle cramps. In some cases, it may also cause respiratory distress or cardiac arrhythmias.

The neuromuscular junction (NMJ) is the specialized synapse or chemical communication point, where the motor neuron's nerve terminal (presynaptic element) meets the muscle fiber's motor end plate (postsynaptic element). This junction plays a crucial role in controlling muscle contraction and relaxation.

At the NMJ, the neurotransmitter acetylcholine is released from the presynaptic nerve terminal into the synaptic cleft, following an action potential. Acetylcholine then binds to nicotinic acetylcholine receptors on the postsynaptic membrane of the muscle fiber, leading to the generation of an end-plate potential. If sufficient end-plate potentials are generated and summate, they will trigger an action potential in the muscle fiber, ultimately causing muscle contraction.

Dysfunction at the neuromuscular junction can result in various neuromuscular disorders, such as myasthenia gravis, where autoantibodies attack acetylcholine receptors, leading to muscle weakness and fatigue.

Phenoperidine is a strong synthetic opioid analgesic, which is primarily used for its analgesic and anesthetic properties in the medical field. It is a derivative of pethidine (meperidine) and functions by binding to opioid receptors in the brain and spinal cord, thereby reducing the perception of pain.

Phenoperidine has a longer duration of action than pethidine and is approximately three to five times more potent. It is used for preoperative medication, as an analgesic during surgery, and for postoperative pain relief. Due to its strong sedative effects, phenoperidine can also be used to induce a twilight sleep or a state of conscious sedation.

It's important to note that the use of phenoperidine is associated with several side effects, including respiratory depression, hypotension, bradycardia, and potential addiction due to its opioid nature. Therefore, it should be used cautiously and under medical supervision, with careful monitoring of the patient's vital signs and overall condition.

Androstanols are a class of steroid compounds that contain a skeleton of 17 carbon atoms arranged in a particular structure. They are derived from androstane, which is a reduced form of testosterone, a male sex hormone. Androstanols have a variety of biological activities and can be found in various tissues and bodily fluids, including sweat, urine, and blood.

In the context of medical research and diagnostics, androstanols are sometimes used as biomarkers to study various physiological processes and diseases. For example, some studies have investigated the use of androstanol metabolites in urine as markers for prostate cancer. However, more research is needed to establish their clinical utility.

It's worth noting that while androstanols are related to steroid hormones, they do not have the same hormonal activity as testosterone or other sex hormones. Instead, they may play a role in cell signaling and other regulatory functions within the body.

Inhalational anesthesia is a type of general anesthesia that is induced by the inhalation of gases or vapors. It is administered through a breathing system, which delivers the anesthetic agents to the patient via a face mask, laryngeal mask airway, or endotracheal tube.

The most commonly used inhalational anesthetics include nitrous oxide, sevoflurane, isoflurane, and desflurane. These agents work by depressing the central nervous system, causing a reversible loss of consciousness, amnesia, analgesia, and muscle relaxation.

The depth of anesthesia can be easily adjusted during the procedure by changing the concentration of the anesthetic agent. Once the procedure is complete, the anesthetic agents are eliminated from the body through exhalation, allowing for a rapid recovery.

Inhalational anesthesia is commonly used in a wide range of surgical procedures due to its ease of administration, quick onset and offset of action, and ability to rapidly adjust the depth of anesthesia. However, it requires careful monitoring and management by trained anesthesia providers to ensure patient safety and optimize outcomes.

Neuromuscular blockade (NMB) is a pharmacological state in which the communication between nerves and muscles is interrupted by blocking the neuromuscular junction, thereby preventing muscle contraction. This condition can be achieved through the use of certain medications called neuromuscular blocking agents (NMBAs). These drugs are commonly used during surgical procedures to facilitate endotracheal intubation, mechanical ventilation, and to prevent patient movement and minimize potential injury during surgery. NMBs are classified into two main categories based on their mechanism of action: depolarizing and non-depolarizing agents.

Depolarizing neuromuscular blocking agents, such as succinylcholine, work by activating the nicotinic acetylcholine receptors at the neuromuscular junction, causing a sustained depolarization and muscle contraction followed by flaccid paralysis. Non-depolarizing neuromuscular blocking agents, such as rocuronium, vecuronium, pancuronium, and atracurium, bind to the receptors without activating them, thereby preventing acetylcholine from binding and transmitting the signal for muscle contraction.

Clinical monitoring of neuromuscular blockade is essential to ensure proper dosing and avoid complications such as residual curarization, which can lead to respiratory compromise in the postoperative period. Monitoring techniques include peripheral nerve stimulation and train-of-four (TOF) assessment to evaluate the depth of neuromuscular blockade and guide the administration of reversal agents when appropriate.

Pyridostigmine Bromide is a medication that belongs to the class of drugs known as cholinesterase inhibitors. It is primarily used in the treatment of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue.

Pyridostigmine works by blocking the action of acetylcholinesterase, an enzyme that breaks down acetylcholine, a neurotransmitter essential for muscle contraction. By preventing the breakdown of acetylcholine, pyridostigmine helps to increase its levels at the neuromuscular junction, thereby improving muscle strength and function.

The bromide salt form of pyridostigmine is commonly used because it is more soluble in water, which makes it easier to administer orally as a liquid or tablet. The medication's effects typically last for several hours, and its dosage may be adjusted based on the patient's response and any side effects experienced.

Common side effects of pyridostigmine include nausea, vomiting, diarrhea, increased salivation, sweating, and muscle cramps. In some cases, higher doses of the medication can lead to more severe side effects such as respiratory distress, seizures, or cardiac arrhythmias. Therefore, it is essential to monitor patients closely while they are taking pyridostigmine and adjust the dosage as necessary to minimize side effects and optimize treatment outcomes.

Enflurane is a volatile halogenated ether that was commonly used as an inhalational general anesthetic agent. Its chemical formula is C3H2ClF5O. It has been largely replaced by newer and safer anesthetics, but it is still occasionally used in certain clinical situations due to its favorable properties such as rapid onset and offset of action, stable hemodynamics, and low blood solubility. However, it can cause adverse effects such as respiratory depression, arrhythmias, and neurotoxicity, particularly with prolonged use or high doses. Therefore, its use requires careful monitoring and management by anesthesia professionals.

Isoquinolines are not a medical term per se, but a chemical classification. They refer to a class of organic compounds that consist of a benzene ring fused to a piperidine ring. This structure is similar to that of quinoline, but with the nitrogen atom located at a different position in the ring.

Isoquinolines have various biological activities and can be found in some natural products, including certain alkaloids. Some isoquinoline derivatives have been developed as drugs for the treatment of various conditions, such as cardiovascular diseases, neurological disorders, and cancer. However, specific medical definitions related to isoquinolines typically refer to the use or effects of these specific drugs rather than the broader class of compounds.

Plastic surgery is a medical specialty that involves the restoration, reconstruction, or alteration of the human body. It can be divided into two main categories: reconstructive surgery and cosmetic surgery.

Reconstructive surgery is performed to correct functional impairments caused by burns, trauma, birth defects, or disease. The goal is to improve function, but may also involve improving appearance.

Cosmetic (or aesthetic) surgery is performed to reshape normal structures of the body in order to improve the patient's appearance and self-esteem. This includes procedures such as breast augmentation, rhinoplasty, facelifts, and tummy tucks.

Plastic surgeons use a variety of techniques, including skin grafts, tissue expansion, flap surgery, and fat grafting, to achieve their goals. They must have a thorough understanding of anatomy, as well as excellent surgical skills and aesthetic judgment.

Paralysis is a loss of muscle function in part or all of your body. It can be localized, affecting only one specific area, or generalized, impacting multiple areas or even the entire body. Paralysis often occurs when something goes wrong with the way messages pass between your brain and muscles. In most cases, paralysis is caused by damage to the nervous system, especially the spinal cord. Other causes include stroke, trauma, infections, and various neurological disorders.

It's important to note that paralysis doesn't always mean a total loss of movement or feeling. Sometimes, it may just cause weakness or numbness in the affected area. The severity and extent of paralysis depend on the underlying cause and the location of the damage in the nervous system.

Halothane is a general anesthetic agent, which is a volatile liquid that evaporates easily and can be inhaled. It is used to produce and maintain general anesthesia (a state of unconsciousness) during surgical procedures. Halothane is known for its rapid onset and offset of action, making it useful for both induction and maintenance of anesthesia.

The medical definition of Halothane is:

Halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) is a volatile liquid general anesthetic agent with a mild, sweet odor. It is primarily used for the induction and maintenance of general anesthesia in surgical procedures due to its rapid onset and offset of action. Halothane is administered via inhalation and acts by depressing the central nervous system, leading to a reversible loss of consciousness and analgesia.

It's important to note that Halothane has been associated with rare cases of severe liver injury (hepatotoxicity) and anaphylaxis (a severe, life-threatening allergic reaction). These risks have led to the development and use of alternative general anesthetic agents with better safety profiles.

In medical terms, the thumb is referred to as "pollex" and it's the first digit of the hand, located laterally to the index finger. It's opposable, meaning it can move opposite to the other fingers, allowing for powerful gripping and precise manipulation. The thumb contains two phalanges bones - the distal and proximal - and is connected to the hand by the carpometacarpal joint, which provides a wide range of motion.

Anesthesia is a medical term that refers to the loss of sensation or awareness, usually induced by the administration of various drugs. It is commonly used during surgical procedures to prevent pain and discomfort. There are several types of anesthesia, including:

1. General anesthesia: This type of anesthesia causes a complete loss of consciousness and is typically used for major surgeries.
2. Regional anesthesia: This type of anesthesia numbs a specific area of the body, such as an arm or leg, while the patient remains conscious.
3. Local anesthesia: This type of anesthesia numbs a small area of the body, such as a cut or wound, and is typically used for minor procedures.

Anesthesia can be administered through various routes, including injection, inhalation, or topical application. The choice of anesthesia depends on several factors, including the type and duration of the procedure, the patient's medical history, and their overall health. Anesthesiologists are medical professionals who specialize in administering anesthesia and monitoring patients during surgical procedures to ensure their safety and comfort.

Isoflurane is a volatile halogenated ether used for induction and maintenance of general anesthesia. It is a colorless liquid with a pungent, sweet odor. Isoflurane is an agonist at the gamma-aminobutyric acid type A (GABAA) receptor and inhibits excitatory neurotransmission in the brain, leading to unconsciousness and immobility. It has a rapid onset and offset of action due to its low blood solubility, allowing for quick adjustments in anesthetic depth during surgery. Isoflurane is also known for its bronchodilator effects, making it useful in patients with reactive airway disease. However, it can cause dose-dependent decreases in heart rate and blood pressure, so careful hemodynamic monitoring is required during its use.

General anesthesia is a state of controlled unconsciousness, induced by administering various medications, that eliminates awareness, movement, and pain sensation during medical procedures. It involves the use of a combination of intravenous and inhaled drugs to produce a reversible loss of consciousness, allowing patients to undergo surgical or diagnostic interventions safely and comfortably. The depth and duration of anesthesia are carefully monitored and adjusted throughout the procedure by an anesthesiologist or certified registered nurse anesthetist (CRNA) to ensure patient safety and optimize recovery. General anesthesia is typically used for more extensive surgical procedures, such as open-heart surgery, major orthopedic surgeries, and neurosurgery.

Fentanyl is a potent synthetic opioid analgesic, which is similar to morphine but is 50 to 100 times more potent. It is a schedule II prescription drug, typically used to treat patients with severe pain or to manage pain after surgery. It works by binding to the body's opioid receptors, which are found in the brain, spinal cord, and other areas of the body.

Fentanyl can be administered in several forms, including transdermal patches, lozenges, injectable solutions, and tablets that dissolve in the mouth. Illegally manufactured and distributed fentanyl has also become a major public health concern, as it is often mixed with other drugs such as heroin, cocaine, and counterfeit pills, leading to an increase in overdose deaths.

Like all opioids, fentanyl carries a risk of dependence, addiction, and overdose, especially when used outside of medical supervision or in combination with other central nervous system depressants such as alcohol or benzodiazepines. It is important to use fentanyl only as directed by a healthcare provider and to be aware of the potential risks associated with its use.

Pancuronium is not preferable in long-term use in ICU-ventilated patients. In Belgium and the Netherlands, pancuronium is ... After administering sodium thiopental to induce coma, pancuronium is delivered in order to stop breathing. Pancuronium is also ... culminating in the development of pancuronium bromide. Pancuronium is designed to mimic the action of two molecules of ... Pancuronium was used in Efren Saldivar's killing spree. It was also used by the Skin Hunters to kill patients in the Polish ...
... pancuronium. SRBAs exert a chelating action that effectively terminates an NMBA ability to bind to nicotinic receptors. The ...
Pancuronium: Pancuronium produces more significant adverse effects due to the blockade of muscarinic M2 receptors in the atria ... Vecuronium and pancuronium: The recommended dosage of vecuronium and pancuronium both vary depending on interpatient ... Vecuronium and pancuronium have an onset of 2 to 5 minutes in adults. The time it takes to recover 25% of neuromuscular control ... Therefore, pancuronium may increase cardiac output, mean arterial pressure, and heart rate. To add on, patients with renal ...
Ingredients such as pancuronium bromide (Pavulon) and alcuronium bromide (Alloferin) can block the acetylcholine receptors of ... "Pancuronium". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-04-19. Daubin, Cédric; Haddad, Lise; Folscheid, Dominique; Boyer, ...
doi:10.1111/j.2042-7158.1965.tb07569.x. Buckett, W.R.; Hewett, C.L.; Savage, D.S. (October 1973). "Pancuronium bromide and ... The structure of malouetine inspired the development of modern aminosteroid muscle relaxants such as pancuronium bromide and ... McKenzie, A.G. (June 2000). "Prelude to pancuronium and vecuronium". Anaesthesia. 55 (6): 551-556. doi:10.1046/j.1365-2044.2000 ...
Optimization of the aminosteroid nucleus led to a sequence of synthesized derivatives, ultimately leading to pancuronium ... "Prelude to pancuronium and vecuronium". Anaesthesia. 55 (6): 551-556. doi:10.1046/j.1365-2044.2000.01423.x. PMID 10866718. ... including the mono-quaternary analogue of pancuronium, later called vecuronium. Vecuronium bromide has been used as part of a ...
Pancuronium and vecuronium measure 1.9 nm, whereas pipecuronium is 2.1 nm. The potency of these compounds follows the same rank ... Pancuronium and some other neuromuscular blocking agents block M2-receptors and therefore affect the vagus nerve, leading to ... This muscarinic blocking effect is related to the acetylcholine moiety on the A ring on pancuronium. Making the N atom on the A ... Moreover, Tubocurarine can produce hypotension effect while Pancuronium can lead to moderate increase in heart rate and small ...
Pancuronium bromide is a derivative of the alkaloid malouetine from the plant Malouetia bequaertiana. Instead of pancuronium, ... Following the administration of thiopental, pancuronium bromide, a paralytic agent, is given. Opponents argue that pancuronium ... Lethal injection dosage: 100 milligrams Pancuronium bromide (Trade name: Pavulon): The related drug curare, like pancuronium, ... Only for pancuronium dibromide, the agent may also be given intramuscularly in a dose of 40 mg. A euthanasia machine may allow ...
Pancuronium bromide "WHOCC - ATC/DDD Index". "Pipecuronium". "Pipecuronium - brand name list from". Drugs.com. Retrieved 2022- ...
Lanier WL, Milde JH, Michenfelder JD (Dec 1985). "The cerebral effects of pancuronium and atracurium in halothane-anesthetized ... Heath ML (Jul 1973). "Bronchospasm in an asthmatic patient following pancuronium". Anaesthesia. 28 (4): 437-440. doi:10.1111/j. ... Kounis NG (Apr 1974). "Letter: Bronchospasm induced by althesin and pancuronium bromide". British Journal of Anaesthesiology. ... pancuronium, vecuronium, and gallamine. Seizures rarely occur. Because atracurium undergoes Hofmann elimination as a primary ...
Pancuronium bromide stopped his breathing by paralyzing his muscles. At 8:23 p.m. EST, Chapman's chest stopped rising, and he ... The three drugs were sodium thiopental, pancuronium bromide, and potassium chloride. Sodium thiopental rendered Chapman ...
Fogdall RP, Miller RD (1974). "Prolongation of a pancuronium-induced neuromuscular blockade by clindamycin". Anesthesiology. 41 ...
Pancuronium (brand name Pavulon) was used in six murders; this drug is used to stop a patient's respiration when they are about ...
... pancuronium bromide (Pavulon) to cause muscle paralysis and respiratory arrest; and potassium chloride to stop the heart. The ...
Speight TM, Avery GS (1972). "Pancuronium Bromide: A Review of its Pharmacological Properties and Clinical Application". Drugs ... "The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man". Anaesthesia. 27 (4): 415-22. doi: ...
Of the many tried as replacements, only a few enjoyed as much popularity as tubocurarine: pancuronium, vecuronium, rocuronium, ... Coleman AJ, Downing JW, Leary WP, Moyes DG, Styles M (October 1972). "The immediate cardiovascular effects of pancuronium, ... tubocurarine and pancuronium". Molecular Pharmacology. 60 (4): 790-796. PMID 11562442. Unna KR (March 1950). "Evaluation Of ...
Shallow pancuronium blockade has been successfully reversed by sugammadex in phase III clinical trials. A study was carried out ... This is very unusual with all but the longest acting neuromuscular blocking drugs (such as gallamine, pancuronium or ... Decoopman M (2007). "Reversal of pancuronium-induced block by the selective relaxant binding agent sugammadex". Eur J ... vecuronium and pancuronium. Although sugammadex has a lower affinity for vecuronium than for rocuronium, reversal of vecuronium ...
It had little to no ganglion blocking activity, with a greater potency than pancuronium. As with other neuromuscular-blocking ... "Comparative clinical evaluation of chandonium iodide and pancuronium bromide as muscle relaxant". J Postgrad Med. 36 (2): 95-99 ... primarily tachycardia that was about the same as the clinically established pancuronium bromide. Candocuronium demonstrated a ... of compounds to which candocuronium belongs are based on the same principle that led to aminosteroids such as pancuronium, ...
On July 27, 2012, the U.S. state of Virginia replaced pancuronium bromide, one of the three drugs used in execution by lethal ... It was designed to be a weaker antagonist at the neuromuscular junction than pancuronium; hence its monoquaternary structure ...
The nondepolarizing muscle relaxants pancuronium, cisatracurium, atracurium, mivacurium, vecuronium and rocuronium also do not ...
... such as pancuronium, which have a similar pharmacodynamic profile, but fewer side effects.[citation needed] The various ... such as rocuronium and pancuronium, have superseded d-tubocurarine for anesthesia during surgery. When used with halothane d- ...
... followed by pancuronium bromide, and then potassium chloride. Coleman declined a last meal. His last words were, "Just tell ...
Mouw RJ, Klumper F, Hermans J, Brandenburg HC, Kanhai HH (1999). "Effect of atracurium or pancuronium on the anemic fetus ...
Kentucky at the time used the then-common combination of sodium thiopental, pancuronium bromide, and potassium chloride. The ...
January 2005). "The application of pancuronium bromide (Pavulon) forensic analyses to tissue samples from an "Angel of Death" ...
The victim remains conscious and alert in a manner similar to the effect of curare or pancuronium bromide. This effect is ...
The perpetrators were shown to have killed mostly elderly patients using the muscle relaxant pancuronium (brand name Pavulon). ...
Perhaps the mixture of sodium pentothal, pancuronium bromide, and potassium chloride in his veins is not to his liking. The ...
Along with pancuronium bromide and potassium chloride, thiopental is used in 34 states of the US to execute prisoners by lethal ... followed by pancuronium bromide to paralyze muscles and stop breathing. Intravenous administration is the most reliable and ... such as 20 mg pancuronium bromide (Pavulon) or 20 mg vecuronium bromide (Norcuron). The muscle relaxant should be given ... intravenously to ensure optimal bioavailability but pancuronium bromide may be administered intramuscularly at an increased ...
Only for pancuronium bromide (Pavulon) are there substantial indications that the agent may also be given intramuscularly in a ... such as 20 mg pancuronium bromide (Pavulon) or 20 mg vecuronium bromide (Norcuron). The muscle relaxant should preferably be ...
Pancuronium is not preferable in long-term use in ICU-ventilated patients. In Belgium and the Netherlands, pancuronium is ... After administering sodium thiopental to induce coma, pancuronium is delivered in order to stop breathing. Pancuronium is also ... culminating in the development of pancuronium bromide. Pancuronium is designed to mimic the action of two molecules of ... Pancuronium was used in Efren Saldivars killing spree. It was also used by the Skin Hunters to kill patients in the Polish ...
Pancuronium is a steroid-based non-depolarising neuromuscular blocker causing muscular relaxation for about 40 to 60 minutes. ... Pancuronium is best avoided in kidney disease as it is partly excreted renally. ...
Pancuronium Bromide Injection, USP is a non-depolarizing NMB agent that is not authorized for use in Canada; however, Health ... Pancuronium Bromide Injection, USP is a non-depolarizing NMB agent that is not currently authorized for use in Canada; however ... US-labelled Pancuronium Bromide Injection, USP DOES NOT HAVE a distinctive red ferrule (metal seal on vial) with white ... Pancuronium bromide is indicated in the United States as an adjunct to general anesthesia to facilitate tracheal intubation and ...
Pancuronium Dibromide - CAS 15500-66-0 - Calbiochem - Find MSDS or SDS, a COA, data sheets and more information. ... Pancuronium Dibromide, nAChR Antagonist, Pancuronium Dibromide. Primary Target: nAChR ... Pancuronium Dibromide. Description. A highly potent competitive antagonist selective for nAChRs (IC50 = 5.5 nM). A very potent ...
... 🐶 Veterinary Use , Indications/Contra , FAERs-F , FAERs-M , Orange Bk , BioActivity , Stem definition. Drug id. CAS ... Pancuronium Bromide. HUMAN PRESCRIPTION DRUG LABEL. 1. 0409-4646. INJECTION, SOLUTION. 1 mg. INTRAVENOUS. ANDA. 20 sections ... pancuronium dibromide A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it ...
And so the pancuronium would prevent the motor manifestation of that procedure so in my mind, the pancuronium does serve a ... Pancuronium Bromide. Pancuronium bromide, commonly known by its brand name Pavulon, is a neuromuscular blocking agent that ... Pancuronium bromide does serve a purpose, however. It places a "chemical veil" between the condemned prisoner and the execution ... In short, pancuronium bromide contributes to the appearance of a peaceful-looking execution. It reassures onlookers-and the ...
Find information on Pancuronium (Pavulon) in Daviss Drug Guide including dosage, side effects, interactions, nursing ... "Pancuronium." Daviss Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/ ... view/Davis-Drug-Guide/51578/all/pancuronium. Vallerand AHA, Sanoski CAC, Quiring CC. Pancuronium. Daviss Drug Guide. F.A. ... Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Pancuronium. In Daviss Drug Guide (18th ed.). F.A. Davis Company. ...
Download CSV: all data on Pancuronium bromide or data on Pancuronium bromide by Sub-ICB Location. ... Pancuronium bromide (1501050L0). Part of chapter 15 Anaesthesia, section 15.1 General anaesthesia, paragraph 15.1.5 ... High-level prescribing trends for Pancuronium bromide (BNF code 1501050L0) across all GP practices in NHS England for the last ...
ETUDE PHARMACOCINETIQUE DU BROMURE DE PANCURONIUM CHEZ LHOMME.. Author. PANNIER MH. Source. S.L.; DA. 1977; PP. (43P.); H.T. 6 ... PANCURONIUM METABOLISME MEDICAMENT PHARMACOLOGIE Keyword (en). MUSCLE RELAXANT PHYSICOCHEMICAL PROPERTIES PHARMACOKINETICS ... "ETUDE PHARMACOCINETIQUE DU BROMURE DE PANCURONIUM CHEZ LHOMME.;s:8:\u0000*\u0000place;s:0:;s:6:\u0000*\u0000pub; ... "ETUDE PHARMACOCINETIQUE DU BROMURE DE PANCURONIUM CHEZ LHOMME.;s:8:\u0000*\u0000place;s:0:;s:6:\u0000*\u0000pub; ...
Complete Ophthalmoplegia as a Complication of Acute corticosteroid- and pancuronium- associated myopathy. In: Neurology. 1991 ... Complete Ophthalmoplegia as a Complication of Acute corticosteroid- and pancuronium- associated myopathy. / Sitwell, Lucian D ... Dive into the research topics of Complete Ophthalmoplegia as a Complication of Acute corticosteroid- and pancuronium- ... title = "Complete Ophthalmoplegia as a Complication of Acute corticosteroid- and pancuronium- associated myopathy", ...
LL Capron; One patients experience with pancuronium bromide. Crit Care Nurse 1 August 1994; 14 (4): 89-92. doi: https://doi. ...
If you are using this medicine for a long time, tell your doctor about any extra stress or anxiety in your life, including other health concerns and emotional stress. Your dose of this medicine might need to be changed for a short time while you have extra stress. Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. Talk to your doctor right away if you have more than one of these symptoms while you are using this medicine: blurred vision, dizziness or fainting, a fast, irregular, or pounding heartbeat, increased thirst or urination, irritability, or unusual tiredness or weakness. This medicine may cause you to get more infections than usual. Avoid people who are sick or have infections and wash your hands often. If you are exposed to chickenpox or measles, tell your doctor right away. If you start to have a fever, chills, sore throat, or any other sign of an infection, call your doctor right away. Check with your doctor right away ...
Detailed drug Information for Kanamycin. Includes common brand names, drug descriptions, warnings, side effects and dosing information.
Pancuronium Other Interactions Certain medicines should not be used at or around the time of eating food or eating certain ...
Acute intermittent porphyria (AIP) is one of the porphyrias, a group of diseases involving defects in heme metabolism and that results in excessive secretion of porphyrins and porphyrin precursors. AIP manifests itself by abdomen pain, neuropathies, and constipation, but, unlike most types of porphyria, patients with AIP do not have a rash.
Table 1: Empiric corrective http://www.health-canada-pharmacy.com/antifungals.html factors of the body weight in context of thermally indifferent ground under body (other ground types: Tab.2) and applied to a body weight of 70 kg; ...
A Comparison of the Neuromuscular Blocking and Vagolytic Effects of ORG NC45 and Pancuronium S. Lee Son, M.B.; S. Lee Son, M.B ... Comparison of the Effects of Pancuronium and Vecuronium in Canine Coronary and Renal Arteries Anesthesiology (January 1998) ... A Comparison of the Neuromuscular Blocking and Vagolytic Effects of ORG NC45 and Pancuronium. Anesthesiology 1981; 55:12-18 doi ...
Among nondepolarizing drugs, pancuronium, atracurium, and vecuronium interactions have been studied. In the absence of specific ... and that of atracurium and pancuronium by approximately 50% compared to N 2O/opioid anesthesia (See Table 4) . The effect of ...
Atracurium, Vecuronium, and Pancuronium Do Not Alter the Minimum Alveolar Concentration of Halothane in Humans Mark R. Fahey, M ... and Pancuronium Do Not Alter the Minimum Alveolar Concentration of Halothane in Humans. Anesthesiology 1989; 71:53-56 doi: ...
Animals were paralyzed using pancuronium bromide (0.1-0.2 mg/kg/h, IV). We monitored vital signs (heart rate, blood pressure, ...
Significantly different effects than Pancuronium. *Duration of action is half that of Pancuronium ...
Neuromuscular blocking agents (pancuronium bromide, succinylcholine chloride, tubocurarine chloride). Procainamide may ...
Pancuronium Bromide. Pegaspargase. Pentazocine (Lactate). Pentetate Calcium Trisodium/Pentetate. Zinc Trisodium. Phentolamine ...
During recording, neuromuscular transmission was blocked by pancuronium bromide (Pavulon; Organon Teknika, Askim, Sweden, ∼0.2 ...
... with pancuronium were required in one study.133 In the case of pancuronium and vecuronium, the increases were offset in the ... Vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J ...
Pancuronium: (Moderate) Limit the period of use of neuromuscular blockers and corticosteroids and only use when the specific ...
neuromuscular blocking agents (e.g., cisatracurium, pancuronium). *other acne medications (e.g., dapsone) ...
neuromuscular-blocking agents (e.g., pancuronium, succinylcholine) *nilotinib *penicillamine *phenytoin. *phosphate supplements ...
Synthetic drugs are available that have fewer unwanted effects-for example, gallamine and pancuronium. ...
  • Past executions have typically involved injecting prisoners with a three-drug "cocktail" of sodium thiopental, pancuronium bromide and potassium chloride. (newscientist.com)
  • Lethal injection is used for capital punishment by the Federal Government and 36 States, at least 30 of which (including Kentucky) use the same combination of three drugs: The first, sodium thiopental, induces unconsciousness when given in the specified amounts and thereby ensures that the prisoner does not experience any pain associated with the paralysis and cardiac arrest caused by the second and third drugs, pancuronium bromide and potassium chloride. (justia.com)
  • The state's current injection protocol calls for three drugs: pentobarbital, pancuronium bromide and potassium chloride. (apnews.com)
  • The first drug is an anesthetic (sodium thiopental), followed by a paralytic agent (pancuronium bromide), and, finally, a drug that causes the heart to stop beating (potassium chloride). (hrw.org)
  • Its shorter duration of action, unique organ-independent elimination, and low incidence of adverse effects have made cisatracurium an appealing alternative to older agents such as pancuronium and vecuronium. (medscape.com)
  • Pancuronium (trademarked as Pavulon) is an aminosteroid muscle relaxant with various medical uses. (wikipedia.org)
  • After administering sodium thiopental to induce coma, pancuronium is delivered in order to stop breathing. (wikipedia.org)
  • Pancuronium is also used as one component of a lethal injection in administration of the death penalty in some parts of the United States. (wikipedia.org)
  • US-labelled Pancuronium Bromide Injection, USP DOES NOT HAVE a distinctive red ferrule (metal seal on vial) with white lettering: "WARNING: PARALYZING AGENT" OR "PARALYZING AGENT" (see Appendix A). (canada.ca)
  • This is the case for US-labelled Pancuronium Bromide Injection, USP (see Appendix A ). This non-standard labelling and packaging may increase the risk of errors in which NMBs are inadvertently selected and administered to patients. (canada.ca)
  • Health Canada has added Pancuronium Bromide Injection, USP to this list, which permits the importation and sale of US-labelled Pancuronium Bromide Injection. (canada.ca)
  • A formulation for preparing Pancuronium Bromide 1-mg/mL Injection. (ijpc.com)
  • Pancuronium is a typical non-depolarizing curare-mimetic muscle relaxant. (wikipedia.org)
  • Pancuronium is designed to mimic the action of two molecules of acetylcholine with the quaternary nitrogen atoms spaced rigidly apart by the steroid rings at a distance of ten atoms (interonium distance). (wikipedia.org)
  • Pancuronium is a steroid-based non-depolarising neuromuscular blocker causing muscular relaxation for about 40 to 60 minutes. (gpnotebook.com)
  • Workers at Organon were inspired by the structure of the aminosteroid alkaloid malouetine to develop a series of aminosteroid neuromuscular blockers based on an androstane nucleus, culminating in the development of pancuronium bromide. (wikipedia.org)
  • In 2007, Michael Munro, a Scottish neonatologist at Aberdeen Maternity Hospital, was cleared of malpractice by the General Medical Council Fitness to Practice panel after giving 23 times the standard dose of pancuronium to two dying neonates. (wikipedia.org)
  • The effects of pancuronium can be at least partially reversed by anticholinesterasics, such as neostigmine, pyridostigmine, and edrophonium. (wikipedia.org)
  • tobramycin increases effects of pancuronium by pharmacodynamic synergism. (medscape.com)
  • Pancuronium is used with general anesthesia in surgery for muscle relaxation and as an aid to intubation or ventilation. (wikipedia.org)
  • Pancuronium bromide is indicated in the United States as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. (canada.ca)
  • Pediatrics Central , peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51578/all/pancuronium. (unboundmedicine.com)
  • In Belgium and the Netherlands, pancuronium is recommended in the protocol for euthanasia. (wikipedia.org)
  • Workers at Organon were inspired by the structure of the aminosteroid alkaloid malouetine to develop a series of aminosteroid neuromuscular blockers based on an androstane nucleus, culminating in the development of pancuronium bromide. (wikipedia.org)
  • The United Kingdom bans the export of pancuronium bromide to the United States due to its use in lethal injections, but not to the Netherlands or Belgium. (wikipedia.org)
  • Pancuronium bromide injection is a nondepolarizing neuromuscular blocking agent chemically designated as the aminosteroid 2 β, 16 β-dipiperidino-5 α-androstane-3 α, 17-β diol diacetate dimethobromide. (nih.gov)
  • Pancuronium bromide injection is supplied as a sterile, isotonic, nonpyrogenic solution for injection. (nih.gov)
  • Pancuronium bromide is a nondepolarizing neuromuscular blocking agent possessing all of the characteristic pharmacological actions of this class of drugs (curariform). (nih.gov)
  • the duration of neuromuscular blockade produced by pancuronium bromide is longer than that of vecuronium at initially equipotent doses. (nih.gov)
  • Pancuronium bromide induced joint contractures in the newborn. (bmj.com)
  • and pancuronium bromide, 15 mg intravenously, followed by endotracheal intubation. (aafp.org)
  • Instead of ending the controversy, I am now convinced that this case will generate debate not only about the constitutionality of the three-drug protocol, and specifically about the justification for the use of the paralytic agent, pancuronium bromide, but also about the justification for the death penalty itself. (motherjones.com)
  • As Justice Stevens noted, pancuronium bromide, the second drug administered during lethal injection's three-drug procedure, is likely to remain at the center of the firestorm. (motherjones.com)
  • A chemical that induces paralysis, pancuronium bromide can mask the signs of a painfully botched execution. (motherjones.com)
  • Critics of the three-drug method maintain that it is problematic because one of the drugs, pancuronium bromide, can mask severe pain by paralyzing the prisoner. (allgov.com)
  • States have found it difficult to obtain the cocktail of drugs they long relied on, such as sodium thiopental, pancuronium bromide and potassium chloride. (wspa.com)
  • Then pancuronium bromide, a muscle relaxant, will be injected which will paralyse his diaphragm and lungs. (jonathangreenonline.com)
  • In 2007, Michael Munro, a Scottish neonatologist at Aberdeen Maternity Hospital, was cleared of malpractice by the General Medical Council Fitness to Practice panel after giving 23 times the standard dose of pancuronium to two dying neonates. (wikipedia.org)
  • The heart rate rise is inversely related to the rate immediately before administration of pancuronium, is blocked by prior administration of atropine, and appears unrelated to the concentration of halothane or dose of pancuronium. (nih.gov)
  • Approximately 40% of the total dose of pancuronium has been recovered in urine as unchanged pancuronium and its metabolites while approximately 11% has been recovered in bile. (nih.gov)
  • A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium . (lookformedical.com)
  • The bag contains drugs suxamethonium and pancuronium, which are paralysing agents and would be lethal if injected. (smh.com.au)
  • The effects of pancuronium can be at least partially reversed by anticholinesterasics, such as neostigmine, pyridostigmine, and edrophonium. (wikipedia.org)
  • Then pancuronium, and finally a massive overdose of potassium chloride are injected. (stackexchange.com)
  • 1981. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. . (cornell.edu)
  • In his report released earlier this month, Ty Alper, associate director of UC Berkeley's Death Penalty Clinic, notes that nearly 98% of all lethal injections which used pancuronium brodmide to kill a human being took place in states where the law says it's inhumane to use the same or similar drugs to kill an animal. (motherjones.com)
  • Pancuronium is used with general anesthesia in surgery for muscle relaxation and as an aid to intubation or ventilation. (wikipedia.org)
  • Anesthesia was induced with fentanyl 50 mcg and pancuronium 1 mg, after premedication with intravenous midazolam 1 mg. (hindawi.com)
  • Pancuronium is also used as one component of a lethal injection in administration of the death penalty in some parts of the United States. (wikipedia.org)
  • Pancuronium is a typical non-depolarizing curare-mimetic muscle relaxant. (wikipedia.org)
  • Like all non-depolarising muscle relaxants, pancuronium has no effect on level of consciousness. (wikipedia.org)
  • These have been largely due to improper or insufficient dosages of anaesthetic in concert with normal dosages of muscle relaxants such as pancuronium. (wikipedia.org)
  • Pancuronium: Theophylline decreases the effect of muscle relaxant. (pediatriconcall.com)
  • Less than 5% of the injected dose is recovered as 17-hydroxy metabolite and 3,17-dihydroxy metabolite, which have been judged to be approximately 50 times less potent than pancuronium. (nih.gov)
  • Pancuronium is designed to mimic the action of two molecules of acetylcholine with the quaternary nitrogen atoms spaced rigidly apart by the steroid rings at a distance of ten atoms (interonium distance). (wikipedia.org)
  • Pancuronium is not preferable in long-term use in ICU-ventilated patients. (wikipedia.org)
  • The Washington Manual , www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51578/all/pancuronium. (unboundmedicine.com)
  • www.drugguide.com/ddo/view/Davis-Drug-Guide/51578/all/pancuronium. (drugguide.com)
  • Besser R, Vogt T, Gutmann L. Pancuronium improves the neuromuscular transmission defect of human organophosphate intoxication. (cdc.gov)
  • The elimination half-life of pancuronium has been reported to range between 89-161 minutes. (nih.gov)